JP Stock MarketDetailed Quotes

4967 Kobayashi Pharmaceutical

Watchlist
  • 5640.0
  • +396.0+7.55%
20min DelayNoon Break Aug 30 11:29 JST
440.20BMarket Cap21.03P/E (Static)

Kobayashi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-8.73%36.65B
9.02%36.49B
4.33%173.46B
4.54%54.34B
5.75%45.49B
3.99%40.16B
2.51%33.47B
7.09%166.26B
9.21%51.98B
5.93%43.02B
Cost of revenue
-0.88%16.85B
9.87%15.53B
4.26%77.08B
4.25%26.07B
6.94%19.88B
4.09%17B
0.95%14.14B
11.21%73.93B
12.49%25.01B
10.51%18.59B
Gross profit
-14.49%19.81B
8.40%20.95B
4.38%96.38B
4.81%28.27B
4.86%25.61B
3.92%23.16B
3.69%19.33B
4.01%92.33B
6.35%26.97B
2.69%24.43B
Operating expense
-13.77%15.36B
11.61%15.92B
7.51%70.59B
14.84%21.88B
6.98%16.63B
3.19%17.82B
3.41%14.27B
4.71%65.66B
1.76%19.05B
6.48%15.55B
Staff costs
----
----
6.97%15.74B
----
----
----
----
6.79%14.71B
----
----
Selling and administrative expenses
----
----
4.91%33.16B
----
----
----
----
-0.57%31.61B
----
----
-Selling and marketing expense
----
----
4.36%27.74B
----
----
----
----
-0.02%26.58B
----
----
-General and administrative expense
----
----
7.86%5.42B
----
----
----
----
-3.38%5.02B
----
----
Research and development costs
----
----
8.13%9B
----
----
----
----
10.70%8.33B
----
----
Depreciation and amortization
----
----
20.18%3.2B
----
----
----
----
11.32%2.67B
----
----
-Depreciation
----
----
24.46%2.08B
----
----
----
----
8.81%1.67B
----
----
-Amortization
----
----
13.03%1.13B
----
----
----
----
15.78%998M
----
----
Rent and land expenses
----
----
4.04%1.52B
----
----
----
----
7.26%1.46B
----
----
Other operating expenses
----
----
15.70%7.97B
----
----
----
----
17.53%6.88B
----
----
Operating profit
-16.89%4.44B
-0.63%5.03B
-3.34%25.78B
-19.29%6.4B
1.14%8.98B
6.41%5.35B
4.46%5.06B
2.31%26.67B
19.28%7.93B
-3.34%8.88B
Net non-operating interest income (expenses)
-28.30%38M
25.00%65M
176.12%185M
53.85%40M
166.67%40M
430.00%53M
225.00%52M
-40.71%67M
18.18%26M
-40.00%15M
Non-operating interest income
-15.00%51M
23.21%69M
151.76%214M
48.39%46M
173.68%52M
300.00%60M
180.00%56M
-35.11%85M
14.81%31M
-34.48%19M
Non-operating interest expense
85.71%13M
0.00%4M
61.11%29M
20.00%6M
200.00%12M
40.00%7M
0.00%4M
0.00%18M
0.00%5M
0.00%4M
Net investment income
-6.68%433M
512.73%227M
-18.78%588M
165.87%110M
-59.41%69M
-21.22%464M
-141.67%-55M
-22.81%724M
-149.55%-167M
220.75%170M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
0
0
890.91%436M
-88.64%5M
431M
0
0
166.67%44M
1,200.00%44M
Income from associates and other participating interests
Special income (charges)
-6,095.71%-4.34B
-3,199.16%-3.93B
33.15%-359M
70.00%-102M
11.69%-68M
-1.45%-70M
-133.33%-119M
-25.76%-537M
-24.54%-340M
-113.89%-77M
Less:Other special charges
10,941.03%4.31B
5,432.86%3.87B
-52.13%146M
-93.00%17M
5.26%20M
-2.50%39M
2,233.33%70M
15,150.00%305M
511.86%243M
111.11%19M
Less:Write off
0.00%31M
8.16%53M
-8.19%213M
-12.37%85M
-17.24%48M
6.90%31M
2.08%49M
-45.41%232M
-70.78%97M
114.81%58M
Other non-operating income (expenses)
-46.86%93M
21.52%192M
-5.68%930M
-125.25%-25M
19.16%622M
-16.27%175M
1.28%158M
-2.76%986M
312.50%99M
-24.24%522M
Income before tax
-88.79%669M
-68.88%1.59B
-1.40%27.56B
-15.29%6.42B
5.92%10.07B
3.56%5.97B
0.00%5.1B
1.14%27.95B
12.40%7.58B
-3.50%9.51B
Income tax
-87.83%208M
-59.03%610M
-8.91%7.22B
-23.04%1.58B
-9.96%2.44B
11.26%1.71B
-8.31%1.49B
0.09%7.93B
7.64%2.06B
-5.01%2.71B
Net income
-89.20%460M
-72.95%976M
1.58%20.34B
-12.39%4.84B
12.26%7.63B
0.73%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
-2.88%6.8B
Net income continuous operations
-89.18%461M
-72.95%976M
1.57%20.34B
-12.40%4.84B
12.25%7.63B
0.76%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
-2.88%6.8B
Noncontrolling interests
0
0
1M
0
Net income attributable to the company
-89.19%460M
-72.95%976M
1.58%20.34B
-12.35%4.84B
12.26%7.63B
0.69%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
-2.88%6.8B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-89.19%460M
-72.95%976M
1.58%20.34B
-12.35%4.84B
12.26%7.63B
0.69%4.26B
3.89%3.61B
1.56%20.02B
14.28%5.52B
-2.88%6.8B
Gross dividend payment
Basic earnings per share
-88.93%6.19
-72.32%13.13
3.29%268.16
-10.53%64.52
14.00%100.29
2.27%55.92
5.71%47.43
2.88%259.63
16.42%72.11
-1.80%87.97
Diluted earnings per share
-88.93%6.1879
-72.32%13.13
3.30%268.16
-10.53%64.52
13.99%100.2785
2.24%55.9058
5.71%47.43
2.86%259.59
16.42%72.11
-1.80%87.97
Dividend per share
0.00%43
0
12.22%101
11.54%58
0
13.16%43
0
8.43%90
13.04%52
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -8.73%36.65B9.02%36.49B4.33%173.46B4.54%54.34B5.75%45.49B3.99%40.16B2.51%33.47B7.09%166.26B9.21%51.98B5.93%43.02B
Cost of revenue -0.88%16.85B9.87%15.53B4.26%77.08B4.25%26.07B6.94%19.88B4.09%17B0.95%14.14B11.21%73.93B12.49%25.01B10.51%18.59B
Gross profit -14.49%19.81B8.40%20.95B4.38%96.38B4.81%28.27B4.86%25.61B3.92%23.16B3.69%19.33B4.01%92.33B6.35%26.97B2.69%24.43B
Operating expense -13.77%15.36B11.61%15.92B7.51%70.59B14.84%21.88B6.98%16.63B3.19%17.82B3.41%14.27B4.71%65.66B1.76%19.05B6.48%15.55B
Staff costs --------6.97%15.74B----------------6.79%14.71B--------
Selling and administrative expenses --------4.91%33.16B-----------------0.57%31.61B--------
-Selling and marketing expense --------4.36%27.74B-----------------0.02%26.58B--------
-General and administrative expense --------7.86%5.42B-----------------3.38%5.02B--------
Research and development costs --------8.13%9B----------------10.70%8.33B--------
Depreciation and amortization --------20.18%3.2B----------------11.32%2.67B--------
-Depreciation --------24.46%2.08B----------------8.81%1.67B--------
-Amortization --------13.03%1.13B----------------15.78%998M--------
Rent and land expenses --------4.04%1.52B----------------7.26%1.46B--------
Other operating expenses --------15.70%7.97B----------------17.53%6.88B--------
Operating profit -16.89%4.44B-0.63%5.03B-3.34%25.78B-19.29%6.4B1.14%8.98B6.41%5.35B4.46%5.06B2.31%26.67B19.28%7.93B-3.34%8.88B
Net non-operating interest income (expenses) -28.30%38M25.00%65M176.12%185M53.85%40M166.67%40M430.00%53M225.00%52M-40.71%67M18.18%26M-40.00%15M
Non-operating interest income -15.00%51M23.21%69M151.76%214M48.39%46M173.68%52M300.00%60M180.00%56M-35.11%85M14.81%31M-34.48%19M
Non-operating interest expense 85.71%13M0.00%4M61.11%29M20.00%6M200.00%12M40.00%7M0.00%4M0.00%18M0.00%5M0.00%4M
Net investment income -6.68%433M512.73%227M-18.78%588M165.87%110M-59.41%69M-21.22%464M-141.67%-55M-22.81%724M-149.55%-167M220.75%170M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 00890.91%436M-88.64%5M431M00166.67%44M1,200.00%44M
Income from associates and other participating interests
Special income (charges) -6,095.71%-4.34B-3,199.16%-3.93B33.15%-359M70.00%-102M11.69%-68M-1.45%-70M-133.33%-119M-25.76%-537M-24.54%-340M-113.89%-77M
Less:Other special charges 10,941.03%4.31B5,432.86%3.87B-52.13%146M-93.00%17M5.26%20M-2.50%39M2,233.33%70M15,150.00%305M511.86%243M111.11%19M
Less:Write off 0.00%31M8.16%53M-8.19%213M-12.37%85M-17.24%48M6.90%31M2.08%49M-45.41%232M-70.78%97M114.81%58M
Other non-operating income (expenses) -46.86%93M21.52%192M-5.68%930M-125.25%-25M19.16%622M-16.27%175M1.28%158M-2.76%986M312.50%99M-24.24%522M
Income before tax -88.79%669M-68.88%1.59B-1.40%27.56B-15.29%6.42B5.92%10.07B3.56%5.97B0.00%5.1B1.14%27.95B12.40%7.58B-3.50%9.51B
Income tax -87.83%208M-59.03%610M-8.91%7.22B-23.04%1.58B-9.96%2.44B11.26%1.71B-8.31%1.49B0.09%7.93B7.64%2.06B-5.01%2.71B
Net income -89.20%460M-72.95%976M1.58%20.34B-12.39%4.84B12.26%7.63B0.73%4.26B3.89%3.61B1.56%20.02B14.28%5.52B-2.88%6.8B
Net income continuous operations -89.18%461M-72.95%976M1.57%20.34B-12.40%4.84B12.25%7.63B0.76%4.26B3.89%3.61B1.56%20.02B14.28%5.52B-2.88%6.8B
Noncontrolling interests 001M0
Net income attributable to the company -89.19%460M-72.95%976M1.58%20.34B-12.35%4.84B12.26%7.63B0.69%4.26B3.89%3.61B1.56%20.02B14.28%5.52B-2.88%6.8B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -89.19%460M-72.95%976M1.58%20.34B-12.35%4.84B12.26%7.63B0.69%4.26B3.89%3.61B1.56%20.02B14.28%5.52B-2.88%6.8B
Gross dividend payment
Basic earnings per share -88.93%6.19-72.32%13.133.29%268.16-10.53%64.5214.00%100.292.27%55.925.71%47.432.88%259.6316.42%72.11-1.80%87.97
Diluted earnings per share -88.93%6.1879-72.32%13.133.30%268.16-10.53%64.5213.99%100.27852.24%55.90585.71%47.432.86%259.5916.42%72.11-1.80%87.97
Dividend per share 0.00%43012.22%10111.54%58013.16%4308.43%9013.04%520
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg